eyepoint logo.png
Primary Endpoint Met in pSivida’s Utilization Study of New Medidur™ Inserter with Smaller Diameter Needle
09 août 2016 10h00 HE | pSivida Corp
WATERTOWN, Mass., Aug. 09, 2016 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ:PSDV); (ASX:PVA), a leader in the development of sustained release drug delivery products primarily for eye diseases,...